The Molecular Regulation of Horizontal Basal Cell Activation in the Olfactory Epithelium
嗅觉上皮水平基底细胞激活的分子调控
基本信息
- 批准号:9886978
- 负责人:
- 金额:$ 67.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-07 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AblationAddressAdultAffectAfferent NeuronsAgeAgingAnosmiaAreaBackBasal CellBiopsyCause of DeathCell Culture TechniquesCell ProliferationCell physiologyCellsCessation of lifeDataDiseaseElderlyEpithelialEpitheliumExcisionFosteringFunctional disorderGene ExpressionGenesGoalsGoldHealthHumanIn SituIn VitroInjuryIntranasal AdministrationKnock-outLesionLifeLigandsMissionMolecularMultipotent Stem CellsMusNOTCH1 geneNational Institute on Deafness and Other Communication DisordersNatural regenerationNoseNotch Signaling PathwayNutritional statusOlfactory EpitheliumPathologicPathway interactionsPlayPopulationPositioning AttributeProcessProteinsProteolysisQuality of lifeRecoveryRegulationReserve Stem CellResortRodentRoleSafetySensorySignal PathwaySignal TransductionSmell PerceptionSupporting CellSystemTestingTherapeuticTissuesTransactivationTransplantationTreatment EfficacyUbiquitinage relatedagedcell typeconditional knockoutepithelial injuryepithelium regenerationexhaustexhaustionextracellularfallsgene repressiongenetic manipulationin vivoinhibitor/antagonistknockout genemulticatalytic endopeptidase complexneurogenesisnotch proteinolfactory sensory neuronsreceptorrepairedresponseselective expressionstem cellssustentacular celltherapeutic targettissue culturetissue stem cellstranscription factor
项目摘要
PROJECT SUMMARY
The capacity of the olfactory epithelium (OE) for replenishing the population of olfactory sensory neurons and
for regenerating the epithelium after injury depends on the persistence and maintained function of stem cells
within that adult tissue. Decline in sensory function in the elderly is accompanied by pathological changes in
the OE that emerge because the normally active olfactory stem and progenitor cells, namely globose basal
cells (GBCs), become disordered and eventually depleted. In this setting, the reserve stem cells, namely the
horizontal basal cells (HBCs), remain dormant despite the neurogenic exhaustion and disappearance of GBCs;
in contrast, if the OE is damaged by an olfactotoxin, the HBCs activate and contribute to the repair of the
epithelium. A therapeutic strategy that accomplishes controllable activation of HBCs in the setting of an
exhausted OE offers possibly the best approach to treating age-related olfactory dysfunction. We have
demonstrated that the transcription factor p63 is the master switch that regulates HBC activation – a
precipitous decline in p63 levels is necessary and sufficient for activation. Further, signaling by Notch1
maintains p63 levels and restrains activation; we hypothesize that the ligand for Notch1 is Jagged1 expressed
by sustentacular cells, since their selective death is sufficient to activate HBCs. We propose 2 Aims in this
application to build on previous advances. Aim 1 focuses on Notch signaling and asks how precisely do the
complexities of the Notch pathway in the OE regulate HBCs? Additional questions address the other signals
that derive from Sus cells to regulate HBCs. Finally, we will extend our studies manipulating Notch signaling
in tissue culture to human HBCs. Aim 2 focuses on the activation process following injury and asks how does
proteasomal degradation of p63 contribute to the decline in protein levels in mouse and in human HBCs?
When completed, we will have achieved a much more thorough understanding of the process by which HBCs
are shifted out of dormancy so that they might contribute to epithelial regeneration. That understanding of
mechanism in both mouse, where genetic manipulations offer profound analytic power, and in humans will
advance our efforts aimed at identifying therapeutic strategies for alleviating olfactory sensory dysfunction,
particularly the sensory loss which accompanies aging.
项目概要
嗅觉上皮 (OE) 补充嗅觉感觉神经元数量的能力
损伤后上皮的再生取决于干细胞的持久性和维持功能
老年人感觉功能的下降伴随着病理变化。
由于正常活跃的嗅觉干细胞和祖细胞(即球状基底细胞)而出现的 OE
在这种情况下,储备干细胞(GBC)变得紊乱并最终耗尽。
尽管神经源性耗竭和 GBC 消失,水平基底细胞 (HBC) 仍然处于休眠状态;
相反,如果 OE 被嗅毒素损坏,HBC 就会激活并有助于修复
在上皮细胞环境中实现 HBC 可控激活的治疗策略。
疲惫的嗅觉可能是治疗与年龄相关的嗅觉功能障碍的最佳方法。
转录因子 p63 是调节 HBC 激活的主开关 –
p63 水平的急剧下降对于激活来说是必要且充分的。
维持 p63 水平并抑制激活;我们勇敢地说 Notch1 的配体是 Jagged1 表达的
由于它们的选择性死亡足以激活 HBC,因此我们提出了 2 个目标。
应用程序以先前的进展为基础,目标 1 重点关注 Notch 信号,并询问如何精确地实现这一点。
OE 中 Notch 通路的复杂性调节 HBC 有其他问题吗?
最后,我们将扩展我们操纵 Notch 信号传导的研究。
目标 2 关注损伤后的激活过程,并询问如何进行。
p63 的蛋白酶体降解会导致小鼠和人类 HBC 中蛋白质水平的下降吗?
完成后,我们将对 HBC 的过程有更彻底的了解。
摆脱休眠状态,以便它们可能有助于上皮再生。
两种小鼠的机制,其中基因操作提供了深刻的分析能力,并且在人类中也会
我们的努力旨在确定缓解嗅觉感觉功能障碍的先进治疗策略,
尤其是随着衰老而出现的感觉丧失。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES E. SCHWOB其他文献
JAMES E. SCHWOB的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES E. SCHWOB', 18)}}的其他基金
Driving the Progeny of Olfactory HBC Stem Cells toward Neuronal Differentiation
驱动嗅觉 HBC 干细胞后代向神经元分化
- 批准号:
10527167 - 财政年份:2022
- 资助金额:
$ 67.03万 - 项目类别:
Driving the Progeny of Olfactory HBC Stem Cells toward Neuronal Differentiation
驱动嗅觉 HBC 干细胞后代向神经元分化
- 批准号:
10642890 - 财政年份:2022
- 资助金额:
$ 67.03万 - 项目类别:
The Molecular Regulation of Horizontal Basal Cell Activation in the Olfactory Epithelium
嗅觉上皮水平基底细胞激活的分子调控
- 批准号:
10331806 - 财政年份:2020
- 资助金额:
$ 67.03万 - 项目类别:
The Molecular Regulation of Horizontal Basal Cell Activation in the Olfactory Epithelium
嗅觉上皮水平基底细胞激活的分子调控
- 批准号:
10201180 - 财政年份:2020
- 资助金额:
$ 67.03万 - 项目类别:
The Molecular Regulation of Horizontal Basal Cell Activation in the Olfactory Epithelium
嗅觉上皮水平基底细胞激活的分子调控
- 批准号:
10554436 - 财政年份:2020
- 资助金额:
$ 67.03万 - 项目类别:
Profiling the transcriptome of globose basal cells of the olfactory epithelium at the single cell level
在单细胞水平上分析嗅上皮球状基底细胞的转录组
- 批准号:
9226320 - 财政年份:2016
- 资助金额:
$ 67.03万 - 项目类别:
AGE-RELATED OLFACTORY LOSS: MECHANISMS AND TREATMENT OPTIONS
与年龄相关的嗅觉丧失:机制和治疗方案
- 批准号:
9103698 - 财政年份:2014
- 资助金额:
$ 67.03万 - 项目类别:
Age-related olfactory loss: mechanisms and treatment options
与年龄相关的嗅觉丧失:机制和治疗选择
- 批准号:
9062427 - 财政年份:2014
- 资助金额:
$ 67.03万 - 项目类别:
Age-related olfactory loss: mechanisms and treatment options
与年龄相关的嗅觉丧失:机制和治疗选择
- 批准号:
8786272 - 财政年份:2014
- 资助金额:
$ 67.03万 - 项目类别:
Age-related olfactory loss: mechanisms and treatment options
与年龄相关的嗅觉丧失:机制和治疗选择
- 批准号:
8786272 - 财政年份:2014
- 资助金额:
$ 67.03万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Mitochondrial proton leak and neonatal brain injury
线粒体质子泄漏与新生儿脑损伤
- 批准号:
10724518 - 财政年份:2023
- 资助金额:
$ 67.03万 - 项目类别:
Genetic and molecular mechanisms of Xbp-1 mediated salivary gland development and differentiation
Xbp-1介导唾液腺发育和分化的遗传和分子机制
- 批准号:
10678146 - 财政年份:2023
- 资助金额:
$ 67.03万 - 项目类别:
Neural pathways for obesity development by AgRP neurons
AgRP 神经元导致肥胖发展的神经通路
- 批准号:
10681993 - 财政年份:2023
- 资助金额:
$ 67.03万 - 项目类别:
The role of dendritic cells in heart valve extracellular matrix remodeling, homeostasis, and disease
树突状细胞在心脏瓣膜细胞外基质重塑、稳态和疾病中的作用
- 批准号:
10672638 - 财政年份:2023
- 资助金额:
$ 67.03万 - 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 67.03万 - 项目类别: